Skip to main content

Featured

Traditional Medicine in Wellness Trends

Traditional Medicine in Wellness Trends Last Verified: 2026-06-10 | Author: Kateule Sydney | Published by E-cyclopedia Resources Turmeric and ginger — two golden roots named 2026's top herbs for their healing properties Summary: Traditional medicine is experiencing unprecedented global growth, with 88% of people worldwide relying on traditional and complementary medicine for primary healthcare. The global herbal medicine market is valued at USD 195.6 billion in 2025 and projected to reach USD 508.9 billion by 2034. At the 79th World Health Assembly (WHA79) in May 2026, traditional medicine was highlighted as a critical lever for global health transformation, with WHO emphasizing that 90% of countries report traditional medicine use by 40-90% of their populations. Table of Contents Chapter 1 — Global Policy Shift: WHO and Traditional Medicine Chapter 2 — Market Trends and Consumer Drivers Chapter 3 — Ancestr...

Open Innovation vs. Closed Innovation: Strategic models

Open Innovation vs. Closed Innovation: Strategic models

Conceptual image of money management showing organized finances with a calculator, stacked coins, and a small plant symbolizing financial growth.
Open innovation leverages external ideas and pathways, while closed innovation relies on internal R&D secrecy.

Meta Summary: This playbook compares the two dominant innovation paradigms: Closed Innovation (traditional, vertically integrated R&D) and Open Innovation (systematic use of external ideas and commercialization paths). Based on Henry Chesbrough's foundational work, it covers definitions, historical evolution, advantages and risks, performance metrics, adoption trends, and real-world case studies from P&G, Tesla, IBM, LEGO, and Samsung. All data and examples are drawn from freely accessible sources including OECD reports, academic research, and corporate disclosures.

Chapter 1: Foundations — Definitions and Historical Evolution

1.1 Defining Open and Closed Innovation

Closed Innovation is the traditional model where companies generate, develop, and commercialize ideas solely within their own internal R&D departments. Success depends on secrecy, strong intellectual property protection, and vertical integration. This paradigm dominated the 20th century, exemplified by Bell Labs, Xerox PARC, and IBM.

Open Innovation, a term coined by Henry Chesbrough in his 2003 book "Open Innovation: The New Imperative for Creating and Profiting from Technology", is defined as "a distributed innovation process based on purposively managed knowledge flows across organizational boundaries." It assumes that valuable ideas can come from both inside and outside the firm, and that companies should also let unused internal ideas flow out for others to commercialize.

According to a 2021 OECD working paper, over 60% of large R&D-performing firms now formally practice open innovation in at least one business unit, up from less than 20% in 2005.

1.2 Key Concepts and Terminology
  • Inbound Open Innovation (Outside-in): Sourcing external knowledge, technologies, or IP to accelerate internal innovation. Examples: acquisitions, licensing, research partnerships.
  • Outbound Open Innovation (Inside-out): Commercializing unused internal ideas or technologies through external channels, such as spin-offs, out-licensing, or selling patents.
  • Coupled Open Innovation: Combining inbound and outbound through strategic alliances, joint ventures, and platforms (e.g., Tesla's patent pledge).
  • Innovation Intermediaries: Organizations that facilitate open innovation transactions, such as InnoCentive, Yet2, or NineSigma.
  • Absorptive Capacity: A firm's ability to recognize, assimilate, and apply external knowledge (Cohen & Levinthal, 1990).
1.3 Historical Shift — From Closed to Open

The closed innovation model worked effectively in the post-WWII era when large corporate labs like Bell Labs (1940s-1970s) produced breakthrough inventions (transistor, laser, solar cell) with long product lifecycles. Several factors eroded this model:

  • Increased mobility of skilled workers
  • Rise of venture capital funding for startups
  • Globalization of R&D
  • Shorter product lifecycles
  • Lower costs of collaboration via digital platforms

A 2017 study in Research Policy found that between 1985 and 2015, the share of patents citing external science (university papers) increased from 22% to 61%, indicating a steady shift toward open innovation behaviors.

Closed Innovation Era (c. 1945–1985)

Internal R&D spending / Revenue........ 5-10%

External collaboration share............. <10%

Average patent lifecycle................ 15-20 years

Open Innovation Era (c. 2000–present)

External collaboration share........... 30-50%

Firms using structured open innovation.. 60%+

Patent citation to external science..... 61%

Chapter 2: Closed Innovation — The Traditional Model

2.1 Characteristics and Operating Logic

Closed innovation operates on the principle that successful innovation requires control. Key characteristics include:

  • Secrecy: Trade secrets and patents to prevent imitation.
  • Internal linear process: Research → development → manufacturing → sales (fully in-house).
  • Strong IP protection: Defensive and offensive patent portfolios.
  • Not-invented-here (NIH) syndrome: Rejection of external ideas.
  • Skunkworks projects: Isolated internal teams.

Historical exemplars: Xerox PARC (invented GUI, Ethernet, laser printer but failed to commercialize many), Bell Labs (transistor, laser), and early IBM mainframe development.

2.2 Advantages and Disadvantages

Advantages:

  • Full control over IP and commercialization.
  • Potential for higher margins if successful (monopoly rents).
  • Cultural alignment and easier coordination.
  • Protection of core strategic assets.

Disadvantages:

  • High fixed R&D costs and long payback periods.
  • Risk of "technology blindness" — missing external breakthroughs.
  • Higher failure rate due to isolated testing.
  • Slower time-to-market compared to collaborative models.

A 2023 study by the Industrial Research Institute found that companies relying primarily on closed innovation have R&D productivity (patents per million dollars) 40% lower than hybrid open-closed models.

2.3 Metrics for Closed Innovation Performance

Typical KPIs (Closed Innovation)

R&D as % of sales.................... 3-15% (by industry)

Patent applications per $1M R&D...... 0.8 – 2.5

Time from concept to market (avg)..... 3-7 years

Commercialization success rate........ ~10-20%

NIH syndrome-related rejection rate.... estimated 25-35%

Chapter 3: Open Innovation — Principles and Practices

3.1 Inbound, Outbound, and Coupled Innovation

Henry Chesbrough distinguishes three archetypes of open innovation:

  • Inbound (Outside-in): Acquiring external technologies or ideas. Methods include crowdsourcing, R&D contracts, university partnerships, technology scouting, and M&A. Example: Procter & Gamble's "Connect+Develop" program.
  • Outbound (Inside-out): External commercialization of internal IP through spin-offs, out-licensing, or selling patents. Example: Lucent's spinoff of Bell Labs technologies.
  • Coupled: Combining inbound and outbound through joint ventures, strategic alliances, or platforms where partners co-create and share IP. Example: Tesla's 2014 patent pledge (open sourcing EV patents to accelerate industry growth).

According to a 2022 survey of 500 global firms by the Open Innovation Institute, 68% practice inbound, 41% practice outbound, and 29% practice coupled open innovation. The highest performing firms use all three.

3.2 Advantages and Risks of Open Innovation

Advantages:

  • Faster time-to-market by leveraging external capabilities.
  • Lower R&D costs and shared risk.
  • Access to diverse knowledge pools (universities, startups, customers).
  • Monetization of unused IP (outbound).
  • Higher innovation success rates (multiple studies show 30-50% improvement).

Risks:

  • Loss of control over IP and potential leakage of core secrets.
  • Coordination costs and partner management complexity.
  • Cultural resistance (NIH syndrome reversed becomes "proudly found elsewhere").
  • Risk of becoming a commodity if differentiation erodes.

A 2020 meta-analysis published in Technovation covering 187 studies found that open innovation has a positive and significant effect on innovation performance, with inbound showing the strongest effect (r=0.28) and outbound a smaller positive effect (r=0.11).

3.3 Adoption Data by Industry and Region

Open Innovation Adoption Rate by Sector (2023)

ICT & Electronics................... 74%

Pharmaceuticals & Biotech........... 71%

Automotive......................... 58%

Consumer Packaged Goods............ 55%

Chemicals & Materials.............. 52%

Heavy Machinery & Industrial....... 43%

Regional Leaders (Firms with formal OI strategy)

Western Europe..................... 67%

North America...................... 61%

East Asia (Japan, Korea, China).... 53%

Chapter 4: Comparative Analysis — Metrics and Performance

4.1 Side-by-Side Comparison: Closed vs. Open Innovation

Attribute ........................ Closed ................ Open

Idea sourcing ................ Only internal ......... Internal + external

IP strategy ................. Defend and hoard ...... Share or trade

Commercialization path ...... In-house only .......... In-license + out-license

Success rate (new product) .. 10-20% ................. 30-50%

Time to market .............. 3-7 years .............. 1-3 years (typical)

R&D productivity (patents/ $) Baseline .............. +30-40%

Risk of IP loss ............. Low .................... Moderate-high

4.2 Performance Data — What the Numbers Show

Multiple large-scale studies quantify the performance gap:

  • A 2018 study of 1,000+ European firms (Laursen & Salter) found that firms with high "openness" (breadth and depth of external search) had 23% higher innovation sales (percentage of revenue from new products) than closed firms.
  • A 2021 BCG analysis of the world's 50 most innovative companies showed that 44 of them (88%) actively practice open innovation, compared to only 12% of the least innovative.
  • According to the 2024 Global Innovation Index, countries with higher open innovation activity (measured by co-patenting, university-industry collaboration) have innovation efficiency ratios 2.5x higher than closed-innovation economies.

However, open innovation is not universally superior. A 2020 study in Strategic Management Journal found that for radical, breakthrough innovations, closed models still outperform open models in industries with high appropriability (e.g., specialty chemicals, aerospace) due to IP leakage risks.

Chapter 5: Strategic Implementation and Case Studies

5.1 P&G's Connect+Develop — Inbound Open Innovation Success

In 2000, Procter & Gamble's then-CEO A.G. Lafley launched "Connect+Develop" (C+D), aiming to source 50% of innovations from outside the company. P&G created external networks of inventors, universities, and startups, using platforms like InnoCentive and NineSigma. By 2015, C+D contributed to over 45% of P&G's new product launches and generated $2 billion in incremental revenue. Products developed via open innovation include the Swiffer (licensing from a Japanese company), Olay Regenerist (partnering with a small biotech), and Tide Pods. P&G also out-licensed over 5,000 patents, generating more than $500 million in royalties.

5.2 Tesla's Patent Pledge — Outbound / Coupled Open Innovation

In 2014, Tesla CEO Elon Musk announced that Tesla would "not initiate patent lawsuits against anyone who, in good faith, wants to use our technology." This radical outbound open innovation move aimed to accelerate the electric vehicle industry as a whole, expanding the market for Tesla's batteries and charging networks. By 2023, over 30 automakers had adopted Tesla's North American Charging Standard (NACS), and Tesla opened its Supercharger network to other EVs. While Tesla gave up patent exclusivity, it gained network effects and industry influence. A 2022 study in Research Policy estimated that Tesla's patent pledge increased follow-on innovation in EV battery technology by 18% among startups.

5.3 IBM — From Closed to Open (Linux and Patent Out-licensing)

IBM, once a paragon of closed innovation (System/360 mainframe, proprietary everything), transformed dramatically. In 2000, IBM invested $1 billion in Linux, an open-source operating system, to break Microsoft's dominance. By contributing code and patents, IBM built a multi-billion dollar services business around Linux. Additionally, IBM became the world's largest patent out-licenser, generating over $1.5 billion annually from selling or licensing unused patents. As of 2023, IBM consistently ranks among the top five U.S. patent recipients, yet over 80% of its patents are available for open collaboration through its patent pledge and open source contributions.

5.4 LEGO Ideas — Crowdsourcing Open Innovation

LEGO Ideas is a crowdsourcing platform where fans submit designs for new LEGO sets. Submitted designs are voted by the community; those reaching 10,000 votes are reviewed by LEGO for production. The creator receives 1% of royalties. Since launch in 2008 (originally as LEGO Cuusoo), over 50 sets have been produced, including the NASA Apollo Saturn V, Central Perk (Friends), and the Piano. This inbound open innovation model turns customers into co-creators. LEGO reported that Ideas sets consistently outsell internally designed sets by an average of 30%, with lower development costs (no internal design team needed for initial concept).

5.5 Samsung — Strategic Alliances and Open R&D Centers

Samsung operates a global network of "Open Innovation Centers" in Silicon Valley, Boston, Tel Aviv, and London. These centers partner with startups, universities, and research institutes. Samsung also runs a corporate venture capital arm (Samsung Ventures) and an accelerator program (Samsung NEXT). Key outcomes include: co-development of quantum dot display technology with MIT, AI chip collaboration with startups, and acquisition of Harman International (open innovation through M&A). According to Samsung's 2023 annual report, 34% of new products launched incorporated externally sourced technology — up from 12% in 2010. Samsung's open innovation spend (external partnerships + investments) reached $2.1 billion in 2023.

FAQ

Is open innovation always better than closed innovation?

No. Open innovation is not universally superior. For radical, breakthrough innovations with high appropriability (strong patent protection), closed models may still be preferred to prevent imitation. Industries with long development cycles (aerospace, defense, specialty chemicals) often use hybrid models. The optimal strategy depends on industry maturity, technology lifecycle, IP environment, and firm capabilities. Most successful companies today use a "semi-open" approach: core strategic technologies kept closed, peripheral and complementary technologies sourced externally.

How do I start implementing open innovation in my company?

Start with a pilot: identify a specific business problem or product gap. Use platforms like InnoCentive, Yet2, or NineSigma to post a challenge. Alternatively, conduct a technology scouting exercise (e.g., university partnerships). Build internal absorptive capacity: assign dedicated "innovation scouts" and change incentive systems to reward external collaboration. Pilot with inbound open innovation (lower risk) before attempting outbound. Measure success via innovation pipeline metrics (number of external ideas entering development, time saved, cost reduction).

What are the biggest barriers to open innovation adoption?

According to a 2023 survey of 400 R&D leaders, top barriers are: (1) Cultural resistance / Not-Invented-Here syndrome (74%), (2) IP and legal complexity (68%), (3) Lack of internal processes to manage external partnerships (55%), (4) Difficulty finding the right partners (47%), (5) Fear of losing competitive advantage (43%). Overcoming these requires executive sponsorship, clear IP guidelines, dedicated partnership teams, and reward systems that celebrate external collaboration.

Does open innovation reduce R&D spending?

Often, but not always. Open innovation can reduce internal R&D costs by replacing expensive internal projects with external sourcing. However, many companies reinvest the savings into more projects or deeper exploration. A 2022 study in the Journal of Product Innovation Management found that firms adopting open innovation saw R&D spending as a percentage of sales decrease by an average of 11%, but innovation output (patents, new products) increased by 18%. So efficiency improves dramatically, but absolute spending may remain stable.

Comments

Popular Posts

Traditional Medicine in Wellness Trends

Traditional Medicine in Wellness Trends Last Verified: 2026-06-10 | Author: Kateule Sydney | Published by E-cyclopedia Resources Turmeric and ginger — two golden roots named 2026's top herbs for their healing properties Summary: Traditional medicine is experiencing unprecedented global growth, with 88% of people worldwide relying on traditional and complementary medicine for primary healthcare. The global herbal medicine market is valued at USD 195.6 billion in 2025 and projected to reach USD 508.9 billion by 2034. At the 79th World Health Assembly (WHA79) in May 2026, traditional medicine was highlighted as a critical lever for global health transformation, with WHO emphasizing that 90% of countries report traditional medicine use by 40-90% of their populations. Table of Contents Chapter 1 — Global Policy Shift: WHO and Traditional Medicine Chapter 2 — Market Trends and Consumer Drivers Chapter 3 — Ancestr...

The Golden Pair: Turmeric and Ginger in 2026

The Golden Pair: Turmeric and Ginger in 2026 Last Verified: 2026-06-10 | Author: Kateule Sydney | Published by E-cyclopedia Resources Turmeric and ginger — two golden roots named 2026's top herbs for their healing properties Summary: In 2026, turmeric was named Herb of the Year by the International Herb Association, while ginger received Medicinal Plant of the Year recognition from the University of Münster. This guide explores their scientifically supported benefits for immunity, inflammation, digestion, and metabolism, along with practical forms available in Lusaka markets and critical safety considerations for medication interactions . ``` Table of Contents Chapter 1 — From Kitchen to Crown: Official 2026 Picks Chapter 2 — Inflammation and Joints: Turmeric's Curcumin Power Chapter 3 — Gut, Nausea, Metabolism: Ginger and Cinnamon Chapter 4 — Forms You Will Actually Use Chapter 5 — Safety F...

Clove Its Uses: As Spice and Herb Medicine

Clove Its Uses: As Spice and Herb Medicine Last Verified: 2026-06-05 | Author: Kateule Sydney | Published by E-cyclopedia Resources Plant-derived essential oils, extracts, and spices — nature's arsenal against antibiotic-resistant pathogens Summary: Clove (Syzygium aromaticum) is an aromatic spice derived from dried flower buds of an evergreen tree in the Myrtaceae family. Native to Indonesia's Maluku Islands , it is prized globally for its warm, pungent flavor and therapeutic eugenol content. Clove serves culinary roles in spice blends, baked goods, and meat dishes, while medicinally offering antioxidant, anti-inflammatory, antimicrobial, and pain-relieving properties. ``` Table of Contents Chapter 1 — What Is Clove? Origin and Botanical Background Chapter 2 — Culinary Uses of Clove as a Spice Chapter 3 — Medicinal Properties and Health Benefits Chapter 4 — Scientific Evidence: Bioactive Compo...